Lilly to acquire Loxo Oncology

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Eli Lilly and Co. and Loxo Oncology Inc. announced a definitive agreement for Lilly to acquire Loxo Oncology for $235 per share in cash, or approximately $8 billion.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Login